The small peptide OGP(10-14) acts through Src kinases and RhoA pathways in Mo-7e cells: Morphologic and immunologic evaluation

Medical Science Monitor

Volumn 14, Issue 6, 2008, Pages

  Mattii, Letizia ^a   Battolla, Barbara ^a   Moscato, Stefania ^a   Fazzi, Rita ^a   Galimberti, Sara ^a   Bernardini, Nunzia ^a   Dolfi, Amelio ^a   Petrini, Mario ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Cell differentiation; Mo 7e; OGP(10 14); RhoA Src kinases; Thrombopoietin

Indexed keywords

OSTEOGENIC GROWTH PEPTIDE; PEPTIDE; PROTEIN TYROSINE KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; THROMBOPOIETIN;

ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; MEGAKARYOBLAST; SIGNAL TRANSDUCTION;

ADP RIBOSE TRANSFERASES; BOTULINUM TOXINS; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; ENZYME ACTIVATION; HISTONES; HUMANS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; PROTO-ONCOGENE PROTEINS C-FYN; PYRIMIDINES; RHOA GTP-BINDING PROTEIN; SRC-FAMILY KINASES; VON WILLEBRAND FACTOR;

EID: 46449123757     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Liu JM, Lawrence F, Kovacevic M et al: The tetrapeptideAcSDKP, an inhibitor of primitive hematopoietic cell proliferation, induces angiogenesis in vitro and in vivo. Blood 2003; 101: 3014-20
2. Greenberg Z, Chorev M, Muhlrad A et al: Structural and functional characterization of osteogenic growth peptide from human serum: identity with rat and mouse homologs. J. Clin. Endocrinol Metab, 1995; 80: 2330-35
3. Smith E, Meyerrose TE, Kohler T et al: Leaky ribosomal scanning in mammalian genomes: significance of histone H4 alternative translation in vivo. Nucleic Acids Research, 2005; 33: 1298-308
4. Gabarin N, Gavish H, Muhlrad A et al: Mitogenic Gi protein-MAP kinase signaling cascade in MC3T3-E1 osteogenic cells: activation by c-terminal pentapeptide of osteogenic growth peptide (OGP 10-14) and attenuation of activation by camp. J Cell Biochem, 2001; 81: 594-602
5. Gurevitch O, Slavin S, Muhlrad A et al: Osteogenic growth peptide increases blood and bone marrow cellularity and enhances engraftment of bone marrow transplants in mice. Blood, 1996; 88: 4719-24
6. Fazzi R, Testi R, Trasciatti S et al: Bone and bone-marrow interactions: haematological activity of osteoblastic growth peptide (OGP)-derived carboxy-terminal pentapeptide. Mobilizing properties on white blood cells and peripheral blood stem cells in mice. Leuk Res, 2002; 26: 19-27
7. Chen ZX, Chang M, Peng YL et al: Osteogenic growth peptide C-terminal pentapeptide [OGP(10-14)] acts on rat bone marrow mesenchymal stem cells to promote differentiation to osteoblasts and to inhibit differentiation to adipocytes. Regul Pept, 2007; 142: 16-23
8. Fazzi R, Galimberti S, Testi R, et al: Bone and bone marrow interactions hematological activity of osteoblastic growth peptide (OGP)-derived carboxy-terminal pentapeptide. II. Action on human hematopoietic stem cells. Leuk Res, 2002; 26: 839-48
9. Fazzi R, Pacini S, Testi R et al: Carboxy-terminal fragment of osteogenic growth peptide in vitro increases bone marrow cell density in idiopathic myelofibrosis. Br J of Haematol, 2003; 121: 76-85
10. Fazzi R, Galimberti S, Pacini S et al: Bone and bone marrow interactions: hematological activity of osteoblastic growth peptide (OGP)-derived carboxy-terminal pentapeptide III. Action on human megakaryocytopoiesis: focus on essential thrombocytemia. Leuk Res, 2004; 28: 1097-105
11. Mattii L, Fazzi R, Moscato S et al: Carboxy-terminal fragment of osteogenic growth peptide regulates myeloid differentiation through RhoA. J Cell Biochem, 2004; 93: 1231-41
12. Miguel SM, Namdar-Attar M, Noh T et al: ERK1/2-activated de novo Mapkapk2 synthesis is essential for osteogenic growth peptide mitogenic signaling in osteoblastic cells. J Biol Chem, 2005; 280: 37495-502
13. Hall A: The cellular functions of small GTP-binding proteins. Science, 1990; 249: 635-40
14. Buchsbaum RJ: Rho activation at a glance. J Cell Sci, 2007; 120: 1149-52
15. Brown MT, Cooper JA: Regulation, substrates and functions of src. Biochim Biophys Acta, 1996; 1287: 121-49
16. Thomas SM, Brugge JS: Cellular functions regulated by Src family kinases. Annu Rev Cell Dev Biol, 1997; 13: 513-609
17. Lannutti BJ, Drachman JG: Lyn tyrosine kinase regulates thrombopoietin-induced proliferation of hematopoietic cell lines and primary megakaryocytic progenitors. Blood, 2004; 103: 3736-43
18. Lannutti BJ, Blake N, Gandhi MJ et al: Induction of polyploidization in leukemic cell lines and primary bone marrow by Src kinase inhibitor SU6656. Blood, 2005; 105: 3875-78
19. Renshaw MW, Toksoz D, Schwartz MA: Involvement of the small GTPase rho in integrin-mediated activation of mitogen-activated protein kinase. J Biol Chem, 1996; 271: 21691-94
20. Ridley AJ, Comoglio PM, Hall A: Regulation of scatter factor/hepatocyte growth factor responses by Ras, Rac, and Rho in MDCK cells. Mol Cell Biol, 1995; 15: 1110-22
21. Mattii L, Bianchi F, Pellegrini S et al: A morphological study of the expression of the small G protein RhoA in resting and activated MDCK cells. Cell Mol Life Sci, 2000; 57: 1990-96
22. Bab I, Chorev M: Osteogenic growth peptide: from concept to drug design. Biopolymers, 2002; 66: 33-48
23. Ridley AJ, Hall A: The small GTP-binding protein rho regulates the assembly of focal adhesios and actin stress fibers in response to growth factors. Cell, 1992; 70: 389-99
24. Hall A: Rho GTPases and the actin cytoskeleton. Science, 1998; 279: 509-14
25. Fortunel NO, Hatzfeld JA, Monier MN, Hatzfeld A: Control of hematopoietic stem/progenitor cell fate by transforming growth factor-beta. Oncol Res, 2003; 13: 445-53
26. Kalina U, Koschmieder S, Hofmann WK et al: Transforming growth factor-beta1 interferes with thrombopoietin-induced signal transduction in megakaryoblastic and erythroleukemic cells. Exp Hematol, 2001; 29: 602-8